Related Experiment Video
Updated: Sep 9, 2025

Slicing and Culturing Pig Hearts under Physiological Conditions
Published on: March 20, 2020
Mixture of experts for multitask learning in cardiotoxicity assessment
Edoardo Luca Viganò1, Mateusz Iwan2, Erika Colombo2
1Laboratory of Environmental Toxicology and Chemistry, Department of Environmental Health Sciences, Instituto Di Ricerche Farmacologiche Mario Negri IRCSS, 20156, Milan, Italy. edoardo.vigano@marionegri.it.
Artificial Intelligence (AI) and Machine Learning (ML) advance toxicology by predicting chemical cardiotoxicity. A multitask neural network model shows high accuracy in identifying potential heart risks, supporting safer chemical assessment.
Area of Science:
- Toxicology
- Biochemistry
- Biomedical Research
- Artificial Intelligence
- Machine Learning
Background:
- Cardiovascular diseases are a leading cause of death globally.
- Chemicals like environmental contaminants, pesticides, food additives, and drugs pose cardiotoxic risks.
- Traditional toxicology testing is time-consuming, resource-intensive, and lacks scalability.
Purpose of the Study:
- To develop and evaluate an Artificial Intelligence (AI) model for predicting chemical cardiotoxicity.
- To explore the benefits of Multitask Neural Networks within an Integrated Approach to Testing and Assessment (IATA).
- To reduce reliance on traditional in vivo testing methods.
Main Methods:
- Utilized Artificial Intelligence (AI) and Machine Learning (ML) methods.
- Developed a Multitask Neural Network model, incorporating Mixture of Experts (MoE) architecture.
- Trained and validated the model on twelve cardiotoxicity endpoints from the Adverse Outcome Pathways Network.
Main Results:
- The multitask model outperformed single-task baseline models.
- Achieved high performance on a holdout set across multiple cardiotoxicity endpoints.
- The best model demonstrated 78% balanced accuracy, 80% sensitivity, and 76% specificity.
Conclusions:
- An advanced multitask model effectively predicts cardiotoxicity mechanisms induced by small molecules.
- The model offers broad mechanistic coverage and performance comparable to state-of-the-art methods.
- This AI model can serve as a valuable component in New Approach Methodologies (NAMs) for prioritizing chemical safety testing.
More Related Videos
08:03Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
Published on: October 20, 2022
14:03High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
Related Concept Videos
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Cardiomyopathy V: Interprofessional Care
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Cardiopulmonary Resuscitation IV: Pharmacological Management